Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo

A Schäfer, F Muecksch, JCC Lorenzi, SR Leist… - Journal of Experimental …, 2020 - rupress.org
… to the traditional antibody Fc-effector functions (ie, antibody-… Fc-mediated effector functions
of neutralizing antibodies may … the role of antibody potency, effector function, and antibody

Beyond binding: antibody effector functions in infectious diseases

LL Lu, TJ Suscovich, SM Fortune, G Alter - Nature Reviews Immunology, 2018 - nature.com
antibody effector functions that exist and contemplate how an increased knowledge of these
functions … Thus, despite the functional potency of IgG3, it has the shortest half-life among all …

Avidity in antibody effector functions and biotherapeutic drug design

SC Oostindie, GA Lazar, J Schuurman… - Nature Reviews Drug …, 2022 - nature.com
… Indeed, binding affinity is a principal driver of potency for some highly successful therapeutic
antibodies that neutralize cytokines, growth factors or complement factors. Binding of the …

Targeting Fc effector function in vaccine design

SI Richardson, PL Moore - Expert Opinion on Therapeutic Targets, 2021 - Taylor & Francis
… Neutralizing antibodies (red) are also able to mediate Fc effector functions, as are non-…
’ encourage the perception that only antibodies that do not neutralize can mediate potent Fc …

Structural motifs involved in human IgG antibody effector functions

J Greenwood, M Clark… - European journal of …, 1993 - Wiley Online Library
… The performance of an antibody in antibody-… ” the function of the cell to which it is targeted.
Studies using matched sets of antibodies [ l , 21 have indicated that IgGl is the most potent

Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function

AW Chung, M Crispin, L Pritchard, H Robinson… - Aids, 2014 - journals.lww.com
… Therefore, mAb glycosylation was assessed to determine if glycan structures were more
highly predictive of potent antibody effector function. Increased galactosylation correlated with …

[HTML][HTML] Conceptual approaches to modulating antibody effector functions and circulation half-life

KO Saunders - Frontiers in immunology, 2019 - frontiersin.org
… counteracts the biologic process can be optimized for selectivity and potency by modifying
the sequence of the antibody-based molecule to enhance or abrogate its interaction with the …

IgG Fc engineering to modulate antibody effector functions

X Wang, M Mathieu, RJ Brezski - Protein & cell, 2018 - academic.oup.com
… modulate effector function, and where appropriate, provide examples of clinical studies where
Fc engineered antibodies have been employed. … Potent antibody therapeutics by design …

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC

A Natsume, R Niwa, M Satoh - Drug design, development and …, 2009 - Taylor & Francis
… cells into mice or establishing human FcγRIII transgenic mice, the actual potency of
engineered antibodies in the clinic is still difficult to foresee by using these models with limited …

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

SI Richardson, BE Lambson, AR Crowley… - PLoS …, 2019 - journals.plos.org
… Using V2-specific antibodies previously isolated from donor CAP256, we showed that the
IgG3 constant region improved both Fc effector function and neutralization potency. This effect …